Ingevity Corporation
NGVT
$71.98
$1.061.50%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.30% | -2.71% | -10.14% | -17.19% | -32.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.30% | -2.71% | -10.14% | -17.19% | -32.43% |
| Cost of Revenue | 13.94% | -3.14% | -19.48% | -28.62% | -47.00% |
| Gross Profit | -3.58% | -2.04% | 8.04% | 8.15% | 4.84% |
| SG&A Expenses | 11.55% | 8.56% | 2.82% | -2.24% | -16.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.55% | -0.60% | -15.34% | -24.25% | -42.42% |
| Operating Income | -12.65% | -9.35% | 11.26% | 15.95% | 23.62% |
| Income Before Tax | -381.94% | -1.07% | 96.05% | 93.89% | 78.78% |
| Income Tax Expenses | 24.53% | 143.46% | 164.64% | 140.40% | 115.59% |
| Earnings from Continuing Operations | -329.75% | -23.81% | 79.87% | 83.86% | 67.62% |
| Earnings from Discontinued Operations | 116.96% | 89.35% | 90.95% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.88% | 61.17% | 88.31% | 49.78% | -215.61% |
| EBIT | -12.65% | -9.35% | 11.26% | 15.95% | 23.62% |
| EBITDA | -11.41% | -9.11% | 3.11% | 5.09% | 11.07% |
| EPS Basic | 64.08% | 60.91% | 88.40% | 49.96% | -214.30% |
| Normalized Basic EPS | -53.69% | -51.43% | 110.09% | 120.17% | 201.75% |
| EPS Diluted | 63.50% | 60.64% | 88.23% | 50.09% | -212.46% |
| Normalized Diluted EPS | -54.12% | -51.72% | 109.75% | 120.36% | 202.89% |
| Average Basic Shares Outstanding | -1.14% | -0.29% | 0.23% | 0.33% | 0.20% |
| Average Diluted Shares Outstanding | -0.47% | 0.25% | 0.76% | 0.52% | 0.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |